630 related articles for article (PubMed ID: 24216286)
21. Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001.
Moraga F; Roca J; Méndez C; Rodrigo C; Pineda V; Martinez A; Baraibar R; Boronat M;
Pediatr Infect Dis J; 2005 Jun; 24(6):510-3. PubMed ID: 15933560
[TBL] [Abstract][Full Text] [Related]
22. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children.
Christie CD; Marx ML; Marchant CD; Reising SF
N Engl J Med; 1994 Jul; 331(1):16-21. PubMed ID: 8202096
[TBL] [Abstract][Full Text] [Related]
23. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
24. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
Kurova N; Timofeeva EV; Guiso N; Macina D
Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
[TBL] [Abstract][Full Text] [Related]
27. Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.
Domenech de Cellès M; Rohani P; King AA
JAMA Pediatr; 2019 Jun; 173(6):588-594. PubMed ID: 31009031
[TBL] [Abstract][Full Text] [Related]
28. Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis.
Langsam D; Anis E; Haas EJ; Gosinov R; Yechezkel M; Grotto I; Shmueli E; Yamin D
Vaccine; 2020 Mar; 38(12):2700-2706. PubMed ID: 32070682
[TBL] [Abstract][Full Text] [Related]
29. Waning protection after fifth dose of acellular pertussis vaccine in children.
Klein NP; Bartlett J; Rowhani-Rahbar A; Fireman B; Baxter R
N Engl J Med; 2012 Sep; 367(11):1012-9. PubMed ID: 22970945
[TBL] [Abstract][Full Text] [Related]
30. Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.
Terranella A; Rea V; Griffith M; Manning S; Sears S; Farmer A; Martin S; Patel M
Vaccine; 2016 May; 34(22):2496-500. PubMed ID: 27038131
[TBL] [Abstract][Full Text] [Related]
31. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
32. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
33. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
34. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
35. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
[TBL] [Abstract][Full Text] [Related]
36. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.
Klein NP; Bartlett J; Fireman B; Aukes L; Buck PO; Krishnarajah G; Baxter R
Vaccine; 2017 Jun; 35(26):3395-3400. PubMed ID: 28506516
[TBL] [Abstract][Full Text] [Related]
37. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
38. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life.
Tozzi AE; Ravà L; Ciofi degli Atti ML; Salmaso S;
Pediatrics; 2003 Nov; 112(5):1069-75. PubMed ID: 14595048
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of acellular pertussis vaccine in early childhood after household exposure.
Schmitt HJ; von König CH; Neiss A; Bogaerts H; Bock HL; Schulte-Wissermann H; Gahr M; Schult R; Folkens JU; Rauh W; Clemens R
JAMA; 1996 Jan; 275(1):37-41. PubMed ID: 8531284
[TBL] [Abstract][Full Text] [Related]
40. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
